Histology Services and Pathology Analysis
Closed Solicitation Posted
- Solicitation number
- FDA-RFQ-1207869
- Agency
- Food and Drug Administration Department of Health and Human Services
- Responses due
- Set-aside
- Total Small Business
Opportunity facts
- Contract number
- 75F40119P10066 Federal contract award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
Notice text
2 versions
Update #2 · Latest ·
Amendment 0001 - Questions and Answers
Response date remains 7 December 2018.
Update #1 ·
The U.S. Food and Drug Administration's (FDA) CDER/OTR requires neuropathology slides prepared by classical histological techniques with a wide range of embedding and sectioning methodologies and staining protocols including traditional H & E (hematoxylin and eosin) staining, IHC (immunohistochemistry) and a variety of proprietary and specialty stains specifically designed to reveal unique features in tissues..
Attachments
| File | Type | Posted |
|---|---|---|
| FDA_RFQ_1207869_Amendment_0001.doc | DOC document | |
| FDA-RFQ-1207869.doc | DOC document |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity